New Genetic Variant Linked to Infantile Spasms and Hypotonia
This study focused on a genetic variant in a gene called CCDC82 and its link to neurodevelopmental disorders, particularly in a young boy with serious health issues.
-
-
New Insights on Treating Epilepsy in CDKL5 Disorder
Researchers studied the effectiveness of antiseizure medications (ASMs) for treating epilepsy in children with Cyclin-dependent kinase-like 5 deficiency disorder (CDD), a serious condition that often leads to drug-resistant seizures.
-
Valproate Therapy Linked to Rare Hypothyroid Symptoms in Child
Researchers studied a young patient with epilepsy who was being treated with a medication called valproate.
-
Drug-Resistant Epilepsy | Epilepsy Research Summaries | Imaging & EEG | Pediatrics | Recent Research
New Tool Predicts Drug-Resistant Epilepsy in Children with TSC
This study focused on children with tuberous sclerosis complex (TSC) who experience epilepsy.
-
New Study Explores Treatment Options for Symptomatic Brain Cavernoma
This study looked at how to best treat brain cavernomas, which are abnormal blood vessel clusters in the brain that can cause symptoms like seizures or bleeding.
-
GLP-1 Receptor Agonists Offer Benefits for Type 2 Diabetes Care
Researchers studied the effects of a type of diabetes medication called glucagon-like peptide-1 receptor agonists (GLP-1RAs) in adults with type 2 diabetes (T2D).
-
Improving Access to Genetic Testing for Neurodevelopmental Disorders
This study looked at how genetic testing is used to diagnose neurodevelopmental disorders (NDDs) in Israel, focusing on children born between 2000 and 2020.
-
Understanding MRI-Negative Epilepsy and Its Challenges
This study looked at people with drug-resistant focal epilepsy who had negative MRI results, meaning no visible lesions were found on their scans.
-
Safe and Efficient Use of Antiseizure Medications
Researchers studied the safety and effectiveness of quickly giving antiseizure medications (ASMs) to patients, focusing on three specific drugs: lacosamide, levetiracetam, and valproate.
